GSA Capital Partners’s NxStage Medical Inc. NXTM Stock Holding History

GSA Capital Partners’s Portfolio NXTM Stock Details NXTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-10,612	Closed	-$296K	–	1959
2018 Q3	$296K	Buy	+10,612	New	+$298K	0.02%	1330
2018 Q1	–	Sell	-28,300	Closed	-$686K	–	1962
2017 Q4	$686K	Buy	+28,300	New	+$746K	0.04%	787
2017 Q2	–	Sell	-98,200	Closed	-$2.63M	–	2089
2017 Q1	$2.63M	Buy	98,200 +26,530	+37%	+$733K	0.14%	149
2016 Q4	$1.88M	Buy	71,670 +6,434	+10%	+$159K	0.11%	229
2016 Q3	$1.63M	Buy	65,236 +24,810	+61%	+$578K	0.09%	333
2016 Q2	$876K	Buy	40,426 +20,046	+98%	+$358K	0.05%	721
2016 Q1	$305K	Buy	+20,380	New	+$342K	0.02%	1297
2015 Q3	–	Sell	-12,111	Closed	-$173K	–	2169
2015 Q2	$173K	Buy	+12,111	New	+$205K	0.01%	1828

Other funds holding NXTM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TAL

TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

WCMNY

Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GSA Capital Partners's NXTM Position: Q4 2018 in Review

GSA Capital Partners sold out of NxStage Medical Inc. (NXTM) in Q4 2018, closing a stake of 10,612 shares — an estimated $296K sold.

GSA Capital Partners first reported a position in NXTM in Q2 2015 and held it in 8 quarters. The position peaked at $2.63M in Q1 2017. 172 funds tracked by Wall St. Rank hold NXTM as of Q4 2018.

GSA Capital Partners reported no remaining NxStage Medical Inc. position as of Q4 2018 after selling out during the quarter.
GSA Capital Partners sold 10,612 NxStage Medical Inc. shares in Q4 2018, an estimated $296K.
GSA Capital Partners first reported a position in NxStage Medical Inc. in Q2 2015 and held it in 8 quarters.
GSA Capital Partners's NxStage Medical Inc. position peaked at $2.63M in Q1 2017.
172 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q4 2018.

Based on GSA Capital Partners's 13F filing for Q4 2018, filed 12 Feb 2019.